Drug profile · INN
metoclopramide hydrochloride
REGLAN
metoclopramide hydrochloride (REGLAN) is a dopamine d2 receptor antagonist. Associated with Quantum Biopharma. Route of administration: nasal. Current US regulatory status: approved.
Drug details — metoclopramide hydrochloride
- US status
- approved
- Class
- —
- Route
- NASAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
metoclopramide hydrochloride (REGLAN) is a dopamine d2 receptor antagonist. Associated with Quantum Biopharma. Route of administration: nasal. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is metoclopramide hydrochloride?
metoclopramide hydrochloride (REGLAN) is a dopamine d2 receptor antagonist. Associated with Quantum Biopharma. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for metoclopramide hydrochloride?
REGLAN is a marketed brand name for metoclopramide hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metoclopramide hydrochloride?
metoclopramide hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.